Anteilseigner
Capital Research & Management Co. (World Investors) (13,38 %) BlackRock Fund Advisors (6,29 %) Franklin Advisers, Inc. (5,99 %) GIC Pte Ltd. (Investment Management) (5,59 %) Palo Alto Investors LP (5,04 %) The Vanguard Group, Inc. (4,96 %) Polar Capital LLP (3,73 %) Barclays Capital, Inc. (2,81 %) Rubric Capital Management LP (2,55 %) SSgA Funds Management, Inc. (2,26 %) JPMorgan Investment Management, Inc. (2,26 %) Stonepine Capital Management LLC (1,90 %) Geode Capital Management LLC (1,89 %) CIBC Asset Management, Inc. (1,67 %) Suvretta Capital Management LLC (1,54 %) Federated MDTA LLC (1,42 %) Morgan Stanley & Co. LLC (0,93 %)
Kontakt
Revance Therapeutics Inc.